Emami Limited (EMAMILTD) AI Stock Analysis

• Market Cap: ₹255.74B
• Dividend Yield: 1.37%
• Average Volume (3M): 21.15K
• Price to Earnings (P/E): 31.1
• Beta (1Y): 0.61
• Revenue Growth: 4.06%
• EPS Growth: 10.78%
• Country: IN
• Employees: 3,289
• Sector: Consumer Defensive
• Sector Strength: 57
• Industry: Household & Personal Products
• EPS (TTM): 3.80
• Shares Outstanding: 439,080,050
• 10 Day Avg. Volume: 23,478
• 30 Day Avg. Volume: 21,146
• PEG Ratio: 2.65
• Price to Book (P/B): 9.26
• Price to Sales (P/S): 6.55
• P/FCF Ratio: 29.31
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹725.20
• Price Target Upside: 24.51% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5

• Rating: 73 Outperform
• Price Target: ₹649.00 ▲(11.43% Upside)

Emami Limited's overall stock score is driven primarily by its strong financial performance, characterized by robust revenue growth and effective debt management. Technical analysis indicates a mixed outlook with some bullish momentum, while valuation metrics suggest the stock may be overvalued relative to peers. The absence of earnings call data and notable corporate events means these factors do not influence the score.

Emami Limited Business Overview & Revenue Model

Company Description

Emami Limited is an Indian multinational conglomerate primarily engaged in the manufacturing and marketing of personal care products and healthcare items. Operating within the fast-moving consumer goods (FMCG) sector, Emami offers a diverse range of products including skin and hair care, health supplements, and over-the-counter (OTC) healthcare products. The company is renowned for its popular brands such as Boroplus, Navratna, Fair and Handsome, and Zandu, which enjoy a strong presence in both domestic and international markets.

How the Company Makes Money

Emami Limited generates revenue through the sale of its wide array of personal care and healthcare products, primarily targeting the mass consumer market. The company’s revenue model is anchored in its extensive distribution network, which spans across urban and rural areas, ensuring a broad reach for its products. Key revenue streams include the sales of skincare products, hair oils, and OTC healthcare products, with significant contributions from established brands like Boroplus and Navratna. Emami also capitalizes on strategic marketing and brand endorsements to strengthen its market position. Additionally, the company benefits from strategic partnerships and collaborations for product innovation and expansion into new markets, which further bolster its earnings.

Emami Limited Financial Statement Overview

Summary

Emami Limited demonstrates impressive financial health with robust revenue growth, strong profitability margins, and effective debt management. The company's consistent performance in generating free cash flow and maintaining a high equity ratio underlines its financial stability and operational efficiency. While slight concerns exist regarding fluctuating net income and increasing liabilities, the overall trajectory remains positive.

Income Statement

Emami Limited has shown a consistent increase in revenue over the years, with a notable revenue growth rate of 6.45% from 2024 to 2025. The company maintains a strong gross profit margin of 68.64% and a net profit margin of 21.17% in 2025, indicating efficient cost management and profitability. The EBIT and EBITDA margins of 38.70% and 26.52% respectively, further highlight the company's strong operational performance. However, the decline in net income from 2022 to 2023 poses a slight concern for sustained profitability.

Balance Sheet

The balance sheet reflects a solid equity base with an equity ratio of 76.26% in 2025, emphasizing financial stability. The debt-to-equity ratio is low at 0.03, showcasing prudent debt management. Return on equity (ROE) is strong at 29.92%, indicating effective use of shareholder funds to generate profit. A notable strength is the reduction in total debt over the years, though the increase in total liabilities from 2024 to 2025 may warrant monitoring.

Cash Flow

The cash flow statement highlights a robust free cash flow growth rate of 15.28% from 2024 to 2025, driven by increased operating cash flow. The operating cash flow to net income ratio of 1.11 indicates healthy cash generation relative to reported profits. The free cash flow to net income ratio of 1.06 suggests strong cash conversion, although the consistent negative investing and financing cash flows could imply ongoing capital investments and debt repayments.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	38.09B	38.09B	35.78B	34.06B	31.58B	28.81B
Gross Profit	24.59B	26.15B	23.78B	22.04B	20.58B	19.34B
EBITDA	10.60B	10.10B	9.90B	9.14B	10.41B	9.53B
Net Income	8.06B	8.06B	7.24B	6.40B	8.39B	4.55B
Balance Sheet
Total Assets	35.34B	35.34B	32.80B	31.10B	30.57B	25.20B
Cash, Cash Equivalents and Short-Term Investments	6.97B	8.26B	4.09B	3.69B	1.83B	4.46B
Total Debt	897.80M	897.80M	939.56M	905.10M	2.82B	1.01B
Total Liabilities	8.40B	8.40B	8.22B	7.97B	9.83B	7.58B
Stockholders Equity	26.95B	26.95B	24.47B	23.03B	20.77B	17.63B
Cash Flow
Free Cash Flow	0.00	8.51B	7.38B	7.08B	1.60B	8.88B
Operating Cash Flow	0.00	8.96B	7.79B	7.49B	6.44B	9.22B
Investing Cash Flow	0.00	-3.40B	-2.05B	-1.13B	-2.35B	-2.27B
Financing Cash Flow	0.00	-5.00B	-5.63B	-6.08B	-4.02B	-6.88B

Emami Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 582.45
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:EMAMILTD, the sentiment is Negative. The current price of 582.45 is below the 20-day moving average (MA) of 585.57, above the 50-day MA of 579.21, and below the 200-day MA of 591.04, indicating a neutral trend. The MACD of 0.63 indicates Positive momentum. The RSI at 48.89 is Neutral, neither overbought nor oversold. The STOCH value of 26.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:EMAMILTD.

Emami Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JYOTHYLAB	74 Outperform	₹121.81B	33.32		1.06%	1.59%	-2.50%
EMAMILTD	73 Outperform	₹255.74B	31.08		1.37%	4.06%	10.78%
CASTROLIND	70 Outperform	₹203.12B	21.24		6.33%	7.57%	8.08%
ZYDUSWELL	67 Neutral	₹122.75B	37.53		0.31%	10.63%	7.53%
FINEORG	65 Neutral	₹146.81B	35.43		0.23%	8.41%	-2.59%
CROMPTON	63 Neutral	₹205.97B	39.11		0.94%	1.99%	10.81%
Sector *	63 Neutral	$20.97B	14.57	-8.07%	3.14%	2.79%	-9.97%

Emami Limited Corporate Events

Emami Limited Announces Virtual AGM and Annual Report Release

Emami Limited has announced the submission of its Integrated Annual Report for the financial year 2024-25, along with the Notice of its 42nd Annual General Meeting (AGM) scheduled for August 29, 2025. The AGM will be held virtually in compliance with regulatory guidelines, and shareholders will receive the report electronically. This move underscores Emami’s commitment to transparency and digital engagement with its stakeholders, aligning with modern corporate governance practices.